Preliminary, Double Blind, Placebo Controlled Trial of the Effect of Glucocorticoid Receptor Antagonist Treatment on Biologic and Symptom Outcomes in Patients With Borderline Personality Disorder and Histories of Childhood Abuse.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Mifepristone (Primary)
- Indications Borderline personality disorders
- Focus Therapeutic Use
Most Recent Events
- 26 Feb 2019 Biomarkers information updated
- 29 Aug 2013 Planned end date changed from 1 Mar 2014 to 1 Mar 2016 as reported by ClinicalTrials.gov.
- 29 Aug 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.